Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DALBAVANCIN vs TELAVANCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DALBAVANCIN vs TELAVANCIN: Safety Overview

Metric DALBAVANCIN TELAVANCIN
Total FAERS Reports 1,107 82
Deaths Reported 54 3
Death Rate 4.9% 3.7%
Hospitalizations 288 25
Average Patient Age 61.0 yrs 50.0 yrs
% Female Patients 46.7% 38.8%
FDA Approval Date May 23, 2014 Sep 11, 2009
Manufacturer Fresenius Kabi USA, LLC Cumberland Pharmaceuticals Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued